Nicolaus Kröger
机构: Professor der Medizin
每年引用次数
引用次数
引用: 49,189
H-指数: 112
I10-指数 : 624
出版物: 2,022
18F-FDG PET/CT for the detection of residual or recurrent disease in myeloma patients after allogeneic stem cell transplantation
Thorsten Derlin , Janos Mester , Susanne Klutmann , Nicolaus Kroeger
The Journal of Nuclear Medicine 50 645 -645
2009
Allogeneic hematopoietic stem cell transplantation using HLA-compatible donors in younger high cytogenetic risk CLL patients results in very high long-term progression-free survival and may therefore favorably compete with sequential targeted therapy
Matthias Eder , Anja van Biezen , Eva Wagner , Antonin Vitek
Leukemia & Lymphoma 58 90 -93
2017
Which Patients with Myelofibrosis Should Receive Allogeneic Stem Cell Transplantation? A Decision Analysis Based on the Systematic Review of 4,341 Patients
Nicolaus Kroeger , Monia Marchetti
Blood 130 3301 -3301
1
2017
TKI discontinuation after allogeneic stem cell transplantation in patients with chronic myeloid leukemia (CML): A retrospective study from the chronic malignances working party (CMWP)
Hugues de Lavallade , Ibrahim Yakoub-Agha , Nicolaus Kroeger , Peter Dreger
Bone Marrow Transplantation 54 52 -54
2019
Second Autologous Stem Cell Transplantation in Poor Stem Cell Mobilizers Multiple Myeloma Patients
Mark Ringhoffer , Marek Trneny , Stefan Schönland , Laurent Garderet
Blood 130 5515 -5515
2017
MRD Status Impact on Secondary Acute Myeloid Leukemia Outcomes after Allogeneic Hematopoietic Cell Transplantation. A Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Ibrahim Yakoub-Agha , Mutlu Arat , Nicolaus Kroeger , Keith M.O. Wilson
Transplantation and Cellular Therapy 27 ( 3)
2021
Acquisition Patterns and Interaction of Molecular, Obvious and Cryptic Cytogenetic Abnormalities in Myelodysplastic Syndromes
Uwe Platzbecker , Friederike Braulke , Katayoon Shirneshan , Nicolaus Kroeger
Blood 130 4260 -4260
2017
Clinical Relevance of Somatic Mutations in Chronic Myelomonocytic Leukemia Undergoing Allogeneic Stem Cell Transplantation
Nico Gagelmann , Anita Badbaran , Rashit Bogdanov , Olivier Nibourel
Blood 134 1713 -1713
2
2019
Metabolic Syndrome Is Common Following Haematopoietic Cell Transplantation (HCT) and Is Associated with Increased Cardiovascular Disease and Second Cancers: An EBMT Cross-Sectional Non-Interventional Study
Diana M Greenfield , Nina Salooja , Christophe Peczynski , Steffie van der Werf
Blood 132 251 -251
1
2018
The Oral Iron Chelator Deferasirox for Treatment of Transfusional Iron Overload After Allogeneic Hematopoietic Cell Transplantation Does Not Appear to Interfere with the Calcineurin Inhibitor Cyclosporin Trough Serum Levels
Haifa Kathrin Al-Ali , Nadja Jaekel , Alexia Nass , Sandra Otto
Blood 116 ( 21) 1826 -1826
3
2010
Tissue Factor (TF) Activation by Antithymocyte Globulin Is Inhibited by a Novel Monoclonal Antibody Specific for Reduced TF Mutated at the Allosteric Cys186-Cys209 Disulfide.
Florian Langer , Brigitte Spath , Francis Ayuketang Ayuk , Nicolaus Kroeger
Blood 116 ( 21) 1132 -1132
2
2010
Comparable Results of HLA-Mismatched Vs HLA-Matched Unrelated Donors for Allogeneic Stem Cell Transplantation Using Pre-Transplant ATG.
Nicolaus Kroeger , Tatjana Zabelina , Thomas Binder , Francis Ayuk
Blood 112 ( 11) 966 -966
2008
Kinetics of Plasma-Cell Chimerism after Allogeneic Stem Cell Transplantation by Real-Time PCR and Its Value To Quantify Minimal Residual Disease in Patients with Multiple Myeloma.
Nicolaus Kroeger , Maria Zagrivnaja , Sabine Schwartz , Anita Badbaran
Blood 106 ( 11) 2748 -2748
2005
Comparison between Anti-Thymocyte Globulin and Alemtuzumab and the Possible Impact of KIR-Ligand Mismatch in Melphalan/Fludarabine Dose-Reduced Conditioning Followed by HLA-Matched and Mismatched Unrelated Stem Cell Transplantation in Patients with Multiple Myeloma.
Nicolaus Kroeger , Brownen Shaw , Simona Iacobelli , Tatjana Zabelina
Blood 104 ( 11) 980 -980
2
2004
Allogeneic Stem Cell Transplantation from Unrelated Donors within the Seventh Decade of Life.
Joachim Dahlke , Tatjana Zabelina , Francis Ayuk , Jens Panse
Blood 106 ( 11) 2062 -2062
2005
Early Bortezomib Following Allogeneic Stem Cell Transplantation (SCT) for Multiple Myeloma To Enhance or Maintain Remission Status.
Nicolaus Kroeger , Tatjana Zabelina , Francis Ayuk , Djordje Atanackovic
Blood 106 ( 11) 2010 -2010
1
2005
Donor KIR Haplotype Genes Significantly Influence Disease-Free and Overall Survival after Myeloablative Conditioning Followed by In Vivo T-Cell Depleted [ATG] Unrelated Stem Cell Transplantation.
Nicolaus Kroeger , Thomas Binder , Heike Schieder , Helmut Renges
Blood 106 ( 11) 2040 -2040
2005
Bortezomib in Combination with High-Dose Dexamethasone and Continuous Low-Dose Oral Cyclophosphamide for Relapsed Multiple Myeloma.
Martin Kropff , Guido Bisping , Peter Liebisch , Orhan Sezer
Blood 106 ( 11) 2549 -2549
25
2005
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
David L. Porter , Edwin P. Alyea , Joseph H. Antin , Marcos DeLima
Biology of Blood and Marrow Transplantation 16 ( 11) 1467 -1503
107
2010
Biomarkers Predict Graft-Vs-Host Disease Outcomes Better Than Clinical Response after One Week of Treatment
Yi-Bin Chen , Andrew C. Harris , Madan Jagasia , Carrie L. Kitko
Biology of Blood and Marrow Transplantation 23 ( 3) 1 -3
2017